350 related articles for article (PubMed ID: 19388223)
1. [Cannabinoids in the control of pain].
Shaladi AM; Crestani F; Tartari S; Piva B
Recenti Prog Med; 2008 Dec; 99(12):616-24. PubMed ID: 19388223
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
3. Plant cannabinoids: a neglected pharmacological treasure trove.
Mechoulam R
Br J Pharmacol; 2005 Dec; 146(7):913-5. PubMed ID: 16205721
[TBL] [Abstract][Full Text] [Related]
4. Established and potential therapeutic applications of cannabinoids in oncology.
Walsh D; Nelson KA; Mahmoud FA
Support Care Cancer; 2003 Mar; 11(3):137-43. PubMed ID: 12618922
[TBL] [Abstract][Full Text] [Related]
5. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
Pertwee RG
Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids, endocannabinoids, and related analogs in inflammation.
Burstein SH; Zurier RB
AAPS J; 2009 Mar; 11(1):109-19. PubMed ID: 19199042
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of cannabinoid receptor ligands: current status.
Singh J; Budhiraja S
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
[TBL] [Abstract][Full Text] [Related]
10. Control of pain initiation by endogenous cannabinoids.
Calignano A; La Rana G; Giuffrida A; Piomelli D
Nature; 1998 Jul; 394(6690):277-81. PubMed ID: 9685157
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
[TBL] [Abstract][Full Text] [Related]
12. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
13. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.
Ashton CH; Moore PB; Gallagher P; Young AH
J Psychopharmacol; 2005 May; 19(3):293-300. PubMed ID: 15888515
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids Part I--legal policies and physiological effects.
Kerwin J
Drug Test Anal; 2013 Jan; 5(1):20-1. PubMed ID: 23225695
[No Abstract] [Full Text] [Related]
17. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
18. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
19. Cannabis in cancer care.
Abrams DI; Guzman M
Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain.
Martin BR; Wiley JL
J Support Oncol; 2004; 2(4):305-14; discussion 314-6. PubMed ID: 15357514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]